{"id":2680,"date":"2020-04-14T14:40:00","date_gmt":"2020-04-14T14:40:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2508233"},"modified":"2020-04-14T14:40:00","modified_gmt":"2020-04-14T14:40:00","slug":"wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/","title":{"rendered":"WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020"},"content":{"rendered":"

WPD Pharmaceuticals Inc. <\/strong>(CSE: WBIO)(FSE: 8SV1) (the “Company” <\/strong>or “WPD”<\/strong>) a clinical stage pharmaceutical company reports that the Company anticipates to resume trading at market open on Monday, April 13, 2020.<\/p>\n

About WPD Pharmaceuticals<\/strong><\/p>\n

WPD is a biotechnology research and development company with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules.  WPD has 10 novel drug candidates with 4 that are in clinical development stage. These drug candidates were researched at institutions including the Mayo Clinic and Emory University, and WPD currently has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.<\/p>\n

WPD has entered into license agreements with Wake Forest University Health Sciences and sublicense agreements with Moleculin Biotech, Inc. and CNS Pharmaceuticals, Inc., respectively, each of which grant WPD an exclusive, royalty-bearing sublicense to certain technologies of the licensor. Such agreements provide WPD with certain research, development, manufacturing and sales rights, among other things.  The sublicense territory from CNS Pharmaceuticals and Moleculin Biotech includes 31 countries in Europe and Asia, including Russia.<\/p>\n

On Behalf of the Board<\/strong><\/p>\n

‘Mariusz Olejniczak’<\/em><\/p>\n

Mariusz Olejniczak
CEO, WDP Pharmaceuticals<\/p>\n

Contact:<\/strong><\/p>\n

Investor Relations
Email: investors@wpdpharmaceuticals.com
Tel: 604-428-7050
Web: www.wpdpharmaceuticals.com<\/p>\n

\n

See Campaign: <\/strong>http:\/\/www.wpdpharmaceuticals.com<\/a>
Contact Information:<\/b>
Investor Relations
\nEmail: investors@wpdpharmaceuticals.com
\nTel: 604-428-7050
\nWeb: www.wpdpharmaceuticals.com<\/p>\n

Tags:<\/b>
<\/a>, Wire<\/a>, Disclosure Newswire<\/a>, United States<\/a>, English<\/a><\/p>\n

\"image\"<\/div>\n

\n

Contact Information:<\/h3>\n

Investor Relations
\nEmail: investors@wpdpharmaceuticals.com
\nTel: 604-428-7050
\nWeb: www.wpdpharmaceuticals.com<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company reports that the Company anticipates to resume trading at market open on Monday, April 13, 2020. About WPD Pharmaceuticals WPD is a biotechnology research and development company with a focus on oncology, namely research and development of medicinal products involving biological compounds and small … Continue reading WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020<\/span><\/a> Continue Reading →<\/span><\/a><\/p>\n","protected":false},"author":46,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[56,3,22,54],"tags":[],"class_list":["post-2680","post","type-post","status-publish","format-standard","hentry","category-disclosure-newswire","category-english","category-united-states","category-wire"],"yoast_head":"\nWPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020 - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020 - Business\" \/>\n<meta property=\"og:description\" content=\"WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company reports that the Company anticipates to resume trading at market open on Monday, April 13, 2020. About WPD Pharmaceuticals WPD is a biotechnology research and development company with a focus on oncology, namely research and development of medicinal products involving biological compounds and small … Continue reading WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020 Continue Reading →\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-14T14:40:00+00:00\" \/>\n<meta name=\"author\" content=\"Asiya\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Asiya\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/\",\"url\":\"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/\",\"name\":\"WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020 - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"datePublished\":\"2020-04-14T14:40:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/3a37b5ed16b9ebaf70290330c45a2e37\"},\"breadcrumb\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/3a37b5ed16b9ebaf70290330c45a2e37\",\"name\":\"Asiya\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d4d7dcc41e3f5a5cad4cf78eca935d2f4c65cc9a91e376789d357e29806bcb91?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d4d7dcc41e3f5a5cad4cf78eca935d2f4c65cc9a91e376789d357e29806bcb91?s=96&d=mm&r=g\",\"caption\":\"Asiya\"},\"sameAs\":[\"https:\/\/icrowdnewswire.com\/fc\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/asiya\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020 - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/","og_locale":"en_US","og_type":"article","og_title":"WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020 - Business","og_description":"WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company reports that the Company anticipates to resume trading at market open on Monday, April 13, 2020. About WPD Pharmaceuticals WPD is a biotechnology research and development company with a focus on oncology, namely research and development of medicinal products involving biological compounds and small … Continue reading WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020 Continue Reading →","og_url":"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/","og_site_name":"Business","article_published_time":"2020-04-14T14:40:00+00:00","author":"Asiya","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Asiya","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/","url":"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/","name":"WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020 - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"datePublished":"2020-04-14T14:40:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/3a37b5ed16b9ebaf70290330c45a2e37"},"breadcrumb":{"@id":"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ipsnews.net\/business\/2020\/04\/14\/wpd-pharmaceuticals-to-resume-trading-on-monday-april-13-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"WPD Pharmaceuticals to Resume Trading on Monday, April 13, 2020"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/3a37b5ed16b9ebaf70290330c45a2e37","name":"Asiya","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d4d7dcc41e3f5a5cad4cf78eca935d2f4c65cc9a91e376789d357e29806bcb91?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4d7dcc41e3f5a5cad4cf78eca935d2f4c65cc9a91e376789d357e29806bcb91?s=96&d=mm&r=g","caption":"Asiya"},"sameAs":["https:\/\/icrowdnewswire.com\/fc"],"url":"https:\/\/ipsnews.net\/business\/author\/asiya\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/2680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/46"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=2680"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/2680\/revisions"}],"predecessor-version":[{"id":2681,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/2680\/revisions\/2681"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=2680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=2680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=2680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}